Epidemiology and risk stratification in acute heart failure.

Heart failure (HF) is a significant cause of morbidity and mortality worldwide. Acute HF is the leading medical cause of hospitalization among people aged > or = 65 years in the United States, European countries, Australia, and New Zealand. Patients hospitalized with HF are at particularly high risk for early mortality and rehospitalization. Outcomes during and after an HF hospitalization are, however, highly variable. The inhospital mortality rates reported for patients hospitalized with HF has varied greatly, ranging from 2% to 20%. Mortality rates in the first 30 days and 1 year after hospitalization, although high, also significantly vary. A large number of individual variables predictive of prognosis in patients hospitalized with acute HF exist. More recent studies have developed and validated models to allow clinicians to more reliably identify patients with HF at lower, intermediate, and higher risk for mortality based on patient characteristics, vital signs, and laboratories at the time of admission. Identification of individual prognostic variables and use of clinical risk prediction tools may be helpful in triaging patients with acute HF and guiding medical decision making. This article will discuss the epidemiology, mortality predictors, and risk stratification models for patients hospitalized with acute HF and provide a perspective on the value of integrating these tools in clinical practice.

[1]  J. Tu,et al.  Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada. , 2005, Archives of internal medicine.

[2]  N Freemantle,et al.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.

[3]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[4]  Prakash Deedwania,et al.  HFSA 2006 comprehensive heart failure practice guideline , 2006 .

[5]  J. Pell,et al.  Evidence of Improving Prognosis in Heart Failure: Trends in Case Fatality in 66 547 Patients Hospitalized Between 1986 and 1995 , 2000, Circulation.

[6]  Peter C. Austin,et al.  Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. , 2003, JAMA.

[7]  C. O'connor,et al.  Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. , 2004, American heart journal.

[8]  H. Krumholz,et al.  Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? , 2002, Journal of cardiac failure.

[9]  K. Adams,et al.  Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, American heart journal.

[10]  H. Krumholz,et al.  Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease. , 2006, Archives of internal medicine.

[11]  H. Krumholz,et al.  Quality of care for elderly patients hospitalized with heart failure. , 1997, Archives of internal medicine.

[12]  W John Boscardin,et al.  Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. , 2005, JAMA.

[13]  A. Ferreira,et al.  N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients , 2004, Circulation.

[14]  N. Freemantle,et al.  The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment , 2003 .

[15]  Luigi Tavazzi,et al.  Acute Heart Failure Syndromes: Current State and Framework for Future Research , 2005, Circulation.

[16]  E. Philbin,et al.  Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data. , 1999, Journal of the American College of Cardiology.

[17]  Christopher M O'Connor,et al.  Risk stratification after hospitalization for decompensated heart failure. , 2004, Journal of cardiac failure.

[18]  C. O'connor,et al.  Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. , 2003, The American journal of cardiology.

[19]  D. Behar,et al.  Long‐term prognosis of acute pulmonary oedema — an ominous outcome , 2000, European journal of heart failure.

[20]  K. Dickstein,et al.  [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. , 2005, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[21]  J. Hollander,et al.  Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. , 2004, Journal of the American College of Cardiology.

[22]  Harlan M Krumholz,et al.  An Administrative Claims Model Suitable for Profiling Hospital Performance Based on 30-Day Mortality Rates Among Patients With Heart Failure , 2006, Circulation.

[23]  Eduardo R Perna,et al.  Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure. , 2005, International journal of cardiology.

[24]  I. Squire,et al.  Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993–2001 , 2003, Heart.

[25]  R. Califf,et al.  Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. , 2002, JAMA.

[26]  G. Fonarow,et al.  Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure , 2003, Circulation.

[27]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[28]  Ilmo Keskimäki,et al.  An international study of hospital readmissions and related utilization in Europe and the USA. , 2002, Health policy.

[29]  C. O'connor,et al.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. , 2004, Journal of the American College of Cardiology.

[30]  T. Rector,et al.  Validation of a risk score for dying within 1 year of an admission for heart failure. , 2006, Journal of cardiac failure.

[31]  Alan S Maisel,et al.  Cardiac biomarkers: a contemporary status report , 2006, Nature Clinical Practice Cardiovascular Medicine.

[32]  A. Laupacis,et al.  Risk-treatment mismatch in the pharmacotherapy of heart failure. , 2005, JAMA.

[33]  C. Hamm,et al.  Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine , 2005, Heart.

[34]  C. Yancy,et al.  Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. , 2006, Journal of the American College of Cardiology.